NCM·Healthcare·$99M·#151 / 520 in Healthcare
COYA Coya Therapeutics, Inc.
59SPECULATIVE
CATEGORY BREAKDOWN
GROWTH100
QUALITY0
STABILITY92
VALUATION36
GOVERNANCE50
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+123.6%
100
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
52 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
30.1%
75
< 25% strong
Price / Sales
Market cap relative to trailing revenue
12.5x
36
< 3x strong
Rule of 40
Growth rate plus operating margin
-160
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
14.8%
75
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+40.3%
0
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE COYA WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when COYA's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.